Related Experiment Video
Updated: Sep 8, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Positive Airway Pressure Therapy for Obstructive Sleep Apnea in High-Risk Pregnancy: A Meta-Analysis
Thamiris D D Cabral1, Renata M Knoll2,3, Jaime Plane4
1Federal Hospital of Bonsucesso, Rio de Janeiro, Brazil.
Positive airway pressure (PAP) therapy may improve glucose metabolism in high-risk pregnant women with obstructive sleep apnea (OSA). However, PAP therapy showed limited effects on other maternal and neonatal outcomes in this patient group.
Area of Science:
- Obstetrics and Gynecology
- Sleep Medicine
- Perinatology
Background:
- Obstructive sleep apnea (OSA) is increasingly recognized as a comorbidity in high-risk pregnancies.
- OSA in pregnancy is associated with adverse maternal and fetal outcomes, including gestational diabetes and hypertensive disorders.
- Positive airway pressure (PAP) therapy is a common treatment for OSA, but its efficacy in high-risk pregnancies requires further investigation.
Purpose of the Study:
- To systematically review and synthesize the evidence on the effects of PAP therapy in high-risk pregnancy patients with OSA.
- To assess the impact of PAP therapy on maternal metabolic parameters, blood pressure, and pregnancy outcomes.
- To evaluate the effects of PAP therapy on neonatal outcomes.
Main Methods:
- A systematic literature search was conducted across major databases (PubMed, Embase, Web of Science, Cochrane Library).
- Included studies compared PAP therapy to no treatment or non-PAP modalities in high-risk pregnant women with OSA.
- Outcomes analyzed included glucose metabolism, insulin resistance, blood pressure, hypertensive disorders, cesarean section, birth weight, and neonatal outcomes.
Main Results:
- Seven studies with 696 patients were included; 328 received PAP therapy.
- PAP therapy was associated with significantly lower fasting plasma glucose (FPG) and improved insulin resistance (HOMA-IR).
- No significant differences were found for other maternal or neonatal outcomes, including hypertensive disorders, cesarean section, or birth weight.
Conclusions:
- PAP therapy may offer benefits for high-risk pregnant women with OSA, particularly in improving glucose metabolism and insulin resistance.
- Current evidence suggests limited impact of PAP therapy on other maternal and neonatal complications.
- Further research is warranted to fully elucidate the role of PAP therapy in managing OSA during high-risk pregnancies.
More Related Videos
12:02Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
Published on: July 30, 2016
04:53Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
Published on: October 18, 2024
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Cardiopulmonary Resuscitation II: ACLS Airway Management
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...